These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 15119593
1. Characterizing bathocuproine self-association and subsequent binding to Alzheimer's disease amyloid beta-peptide by NMR. Yao S, Cherny RA, Bush AI, Masters CL, Barnham KJ. J Pept Sci; 2004 Apr; 10(4):210-7. PubMed ID: 15119593 [Abstract] [Full Text] [Related]
2. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide. Danielsson J, Pierattelli R, Banci L, Gräslund A. FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176 [Abstract] [Full Text] [Related]
3. Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease. Cherny RA, Barnham KJ, Lynch T, Volitakis I, Li QX, McLean CA, Multhaup G, Beyreuther K, Tanzi RE, Masters CL, Bush AI. J Struct Biol; 2000 Jun; 130(2-3):209-16. PubMed ID: 10940226 [Abstract] [Full Text] [Related]
4. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease. Ma QF, Hu J, Wu WH, Liu HD, Du JT, Fu Y, Wu YW, Lei P, Zhao YF, Li YM. Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111 [Abstract] [Full Text] [Related]
5. Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. Esler WP, Stimson ER, Ghilardi JR, Lu YA, Felix AM, Vinters HV, Mantyh PW, Lee JP, Maggio JE. Biochemistry; 1996 Nov 05; 35(44):13914-21. PubMed ID: 8909288 [Abstract] [Full Text] [Related]
6. Two-site binding of beta-cyclodextrin to the Alzheimer Abeta(1-40) peptide measured with combined PFG-NMR diffusion and induced chemical shifts. Danielsson J, Jarvet J, Damberg P, Gräslund A. Biochemistry; 2004 May 25; 43(20):6261-9. PubMed ID: 15147210 [Abstract] [Full Text] [Related]
7. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. Ha C, Ryu J, Park CB. Biochemistry; 2007 May 22; 46(20):6118-25. PubMed ID: 17455909 [Abstract] [Full Text] [Related]
8. In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics. Esler WP, Stimson ER, Ghilardi JR, Vinters HV, Lee JP, Mantyh PW, Maggio JE. Biochemistry; 1996 Jan 23; 35(3):749-57. PubMed ID: 8547255 [Abstract] [Full Text] [Related]
9. Stereochemical specificity of Alzheimer's disease beta-peptide assembly. Esler WP, Stimson ER, Fishman JB, Ghilardi JR, Vinters HV, Mantyh PW, Maggio JE. Biopolymers; 1999 May 23; 49(6):505-14. PubMed ID: 10193196 [Abstract] [Full Text] [Related]
13. Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease. Mekmouche Y, Coppel Y, Hochgräfe K, Guilloreau L, Talmard C, Mazarguil H, Faller P. Chembiochem; 2005 Sep 26; 6(9):1663-71. PubMed ID: 16078307 [Abstract] [Full Text] [Related]
14. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A, Döbeli H, Bohrmann B. Neuroscience; 2006 Dec 01; 143(2):461-75. PubMed ID: 17008022 [Abstract] [Full Text] [Related]
17. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Sastre M, Calero M, Pawlik M, Mathews PM, Kumar A, Danilov V, Schmidt SD, Nixon RA, Frangione B, Levy E. Neurobiol Aging; 2004 Sep 01; 25(8):1033-43. PubMed ID: 15212828 [Abstract] [Full Text] [Related]
19. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z. Neuroscience; 2007 Jun 15; 147(1):28-36. PubMed ID: 17499931 [Abstract] [Full Text] [Related]